Co-occurring alterations in the RAS-MAPK pathway limit response to MET inhibitor treatment in MET exon 14 skipping mutation positive lung cancer

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Cancer Oncology

Medicine

Internal Medicine

Kras

Show all topics

DOI

10.1101/374181

License

cc-no